Role of Spinal Load in the Pathophysiology of Lumbar Spinal Stenosis (RoLSSroice)
RoLSSroice - Role of Spinal Load in the Pathophysiology of Lumbar Spinal Stenosis: A Translational Approach Combining Clinical and Radiological Parameters, in Vivo Biomechanical Experiments and Advanced in Silico Musculoskeletal Modeling
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Cordula Netzer, PD Dr. med.
- Phone Number: +41 61 265 78 30
- Email: cordula.netzer@usb.ch
Study Contact Backup
- Name: Ilona Ahlborn
- Email: ilona.ahlborn@usb.ch
Study Locations
-
-
-
Basel, Switzerland, 4031
- Department of Spine Surgery, University Hospital Basel
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- age > 30 years
- BMI < 35 kg/m2
- diagnosed sLSS
- clinical symptoms for at least 6 months
- intermittent neurogenic claudication with limitations of their walking ability due to symptoms in the lower back and or in one or both legs
- unsuccessful conservative treatment
- confirmation of the LSS through MRI
- scheduled for surgery
Exclusion Criteria:
- inability to provide informed consent
- previous spine surgery
- use of walking aids
- other neurologic disorders affecting gait
- MRI incompatibility
- pregnancy
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Oswestry disability index (ODI)
Time Frame: At baseline and at one-year follow-up
|
Disability related to sLSS will be assessed with the ODI, which is considered the gold standard of low back functional outcome tools.
The ODI is a questionnaire comprising 10 self-administered items that quantify a patient's perceived level of functional disability.
Each of the items relates to a different area of functional impairment and consists of six statements, which are scored from zero to five points.
|
At baseline and at one-year follow-up
|
|
Change in Dynamic compensation
Time Frame: At baseline and at one-year follow-up
|
Dynamic compensation is defined as the difference between static and dynamic sagittal spinal alignment.
Six possible gait events are available to choose from for the definition of dynamic sagittal spinal balance (left and right; heel-strike, toe-off, midstance).
Dynamic sagittal spinal balance may be defined as sagittal spinal balance during left/right midstance, left/right heel strike and/or left/right toe off.
The most appropriate gait event to calculate dynamic sagittal spinal balance will be used.
|
At baseline and at one-year follow-up
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Sagittal spinal balance assessed using motion capture
Time Frame: At baseline and at one-year follow-up
|
The curvature of the lumbar and thoracic spine during stance and during walking will be computed from the marker data using MATLAB™ software.
A cubic polynomial function will be fitted to the marker positions in each time frame, approximating an S-shaped spine curvature with thoracic kyphosis (TK) and lumbar lordosis (LL) curves.
The workflow used to calculate sagittal spinal balance parameters is based on the calculation methods for radiological sagittal spinal balance parameters.
The set of marker-based sagittal spinal balance parameters comprises LL, TK, sagittal vertical axis (SVA), spino-sacral angle (SSA), spine inclination (SI).
The data obtained using motion capture will be used to estimate spinal load using musculoskeletal modeling.
|
At baseline and at one-year follow-up
|
|
Change in Sagittal Spinal Balance assessed using EOS
Time Frame: At baseline and at one-year follow-up
|
Sagittal spinal balance parameters from EOS radiological images are calculated semi-automatically using the sterEOS software provided by the EOS company.
This workflow allows the calculation of four sagittal spinal balance parameters: SVA, SSA, LL and TK.
LL is calculated as the angle between the tangents on the superior L1 and inferior L5 vertebral endplates.
TK is calculated as the angle between the tangents on the superior T4 and inferior T12 vertebral endplates.
SVA is measured as the horizontal distance between C7 plumb line and the posterior-superior corner of the S1 vertebra.
SSA is defined as the angle between the line connecting the center of the C7 vertebra to the center of the S1 endplate and the line parallel to the superior S1 endplate.
|
At baseline and at one-year follow-up
|
|
Change in Muscle fatigue assessed using electromyography (EMG)
Time Frame: At baseline and at one-year follow-up
|
Muscle fatigue will be assessed as the decrease in median EMG frequency.
|
At baseline and at one-year follow-up
|
|
Change in Muscle fatigue assessed by fatigue exercise duration
Time Frame: At baseline and at one-year follow-up
|
The fatigue exercise duration will be measured using a stopwatch.
Time is stopped from the point where the patients starts the exercise by no longer supporting the torso with their hands until the termination of the exercise by supporting the torso.
|
At baseline and at one-year follow-up
|
|
Change in Radiological parameter: Muscle atrophy
Time Frame: At baseline and at one-year follow-up
|
The measurement of muscle atrophy allows quantifying abdominal and paraspinal muscle degeneration.
The analysis will be performed using ImageJ image analysis software (Version 1.52t, National Institutes of Health, Bethesda, Maryland).
|
At baseline and at one-year follow-up
|
|
Change in Radiological parameter: Fatty infiltration
Time Frame: At baseline and at one-year follow-up
|
The measurement of fatty infiltration allows quantifying abdominal and paraspinal muscle degeneration.
The analysis will be performed using ImageJ image analysis software (Version 1.52t, National Institutes of Health, Bethesda, Maryland).
|
At baseline and at one-year follow-up
|
|
Change in Radiological parameter: Muscle cross-sectional area (CSA)
Time Frame: At baseline and at one-year follow-up
|
For L1 to L5, the cross-sectional area (CSA) of the abdominal and paraspinal muscles on each side will be measured, including the multifidus and the erector spinae (longissimus and iliocostalis) muscles, and the CSA of the vertebral body.
The relative CSA (rCSA) will be defined as the ratio between muscle CSA and vertebral body CSA and calculated for each level and side.
The CSA of lean muscle in the region of interest will be defined as LeanCSA and measured on each side.
The ratio of LeanCSA to the paraspinal muscle CSA will be defined as functional CSA (LeanCSA/CSA), represented as % muscle CSA and calculated for each level and side.
Overall CSA, rCSA and LeanCSA will be computed as average CSA (aCSA), average rCSA (arCSA) and average LeanCSA (aLeanCSA) across all levels considering the muscle as a single unit for each side.
|
At baseline and at one-year follow-up
|
|
Change in Radiological parameter: Stenosis severity
Time Frame: At baseline and at one-year follow-up
|
Stenosis severity will be classified according to Schizas (Grade A stenosis is the mildest, with abundant cerebrospinal fluid inside the dural sac.
In grade B stenosis, the rootlets occupy the whole of the dural sac, but they can still be individualized.
In grade C, no rootlets can be recognized but epidural fat can be visualized posteriorly.
In grade D, in addition to no rootlets being recognizable, there is no epidural fat posteriorly).
|
At baseline and at one-year follow-up
|
|
Change in Radiological parameter: Segmental instability
Time Frame: At baseline and at one-year follow-up
|
Segmental instability will be determined as a relative shift in anteroposterior position of two adjacent segments between the upright standing radiograph and the lying MRI of more than 3mm.
|
At baseline and at one-year follow-up
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Quality of life (EQ-5D-5L)
Time Frame: At baseline and at one-year follow-up
|
The EQ-5D-5L comprises 5 questions/dimensions (mobility, self-care, usual activities, pain, depression) with Likert-scale response and a visual analogue scale where patients are asked to rate their overall health from 0 (the worst health imaginable) to 100 (the best health imaginable).
Each dimension allows to choose five levels labelled as (1) 'not /no problems', (2) 'slight problems', (3) 'moderate problems', (4) 'severe problems', and (5) 'unable to' (mobility, self-care, usual activities), 'extreme' (pain/depression), or 'extremely' (anxiety/depression). Using the EQ-5D-5L, a total of 3125 different health states can be described.
The final EQ index is a number between 0 and 1, with 0 indicating the poorest possible health (a state as bad as being dead) and 1 indicating the best possible health.
|
At baseline and at one-year follow-up
|
|
Change in Swiss spinal stenosis score
Time Frame: At baseline and at one-year follow-up
|
The Swiss Spinal Stenosis Questionnaire is a self-report outcome questionnaire for patients with LSS and assesses the intensity of symptoms, physical function, and patient satisfaction following treatment.
|
At baseline and at one-year follow-up
|
|
Change in Tampa scale of kinesiophobia
Time Frame: At baseline and at one-year follow-up
|
The Tampa scale is a 17-item self-report questionnaire based on the assessment of fear of exercise, fear of physical activity, and fear avoidance.
It consists of two subscales.
While activity avoidance revolves around the reflection of activities that may increase pain or cause injury, somatic focus investigates the reflection of beliefs and underlying serious conditions.
|
At baseline and at one-year follow-up
|
|
Change in Core Outcome Measures Index for the back (COMI back)
Time Frame: At baseline and at one-year follow-up
|
The COMI is a validated 11-item self-report questionnaire for assessing the main outcomes of importance to patients back problems.
|
At baseline and at one-year follow-up
|
|
Change in Upper body motion (inertial sensor data)
Time Frame: At baseline and at one-year follow-up
|
During all tasks, inertial sensor data will be collected.
Inertial sensors (Blue Trident IMU, Vicon, Oxford, UK) will be placed on the subjects' femora, thoracic and lumbar spine and on the sternum.
Accelerations and angular velocity will be captured for all movement assessments.
|
At baseline and at one-year follow-up
|
|
Change in Manual testing for muscle strength
Time Frame: At baseline and at one-year follow-up
|
Selected muscles of the legs will be assessed according to Janda's M5/5 levels of strength.
In a sitting position: Hip flexion / M. iliopsoas (L2), Knee extension/ M. quadriceps femoris (L3).
In a supine lying position: Foot extension (lift up) / M. tibialis anterior (L4), Lifting the big toe/ M extensor hallucis longus (L5).
Foot extension (push down)/ M. gastrocnemius (S1).
|
At baseline and at one-year follow-up
|
|
Change in Physical activity level
Time Frame: first assessment period: 9 days after the baseline measurement on test day 1; second period: 6 months after the spine surgery; third period: for 9 days at the one-year follow-up visit
|
Physical activity (PA) level will be assessed using an activity monitor (GENEActiv, Activinsights, Kimbolton, UK) during three periods of time (9 days each).
|
first assessment period: 9 days after the baseline measurement on test day 1; second period: 6 months after the spine surgery; third period: for 9 days at the one-year follow-up visit
|
|
Change in Back performance scale
Time Frame: At baseline and at one-year follow-up
|
The Back performance scale is an assessment consisting of a series of five movement activities that require mobility of the trunk.
The activities (sock test, pick-up test, roll-up test, fingertip-to-floor test, and lift test) all require sagittal-plane mobility and are scored from 0 (can easily do) to 3 (hard/limited to do.
|
At baseline and at one-year follow-up
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Cordula Netzer, PD Dr. med., Department of Spine Surgery, University Hospital Basel
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 2022-01170; mu22Netzer3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.